BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 26159728)

  • 21. Impact of traumatic and violent victimization experiences in individuals with schizophrenia and schizoaffective disorder.
    Newman JM; Turnbull A; Berman BA; Rodrigues S; Serper MR
    J Nerv Ment Dis; 2010 Oct; 198(10):708-14. PubMed ID: 20921860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia patients with a history of severe violence differ from nonviolent schizophrenia patients in perception of emotions but not cognitive function.
    Silver H; Goodman C; Knoll G; Isakov V; Modai I
    J Clin Psychiatry; 2005 Mar; 66(3):300-8. PubMed ID: 15766295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social cognition and neurocognitive deficits in schizophrenia.
    Lancaster RS; Evans JD; Bond GR; Lysaker PH
    J Nerv Ment Dis; 2003 May; 191(5):295-9. PubMed ID: 12819548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia.
    Eack SM; Pogue-Geile MF; Greenwald DP; Hogarty SS; Keshavan MS
    Psychol Med; 2011 Jun; 41(6):1253-61. PubMed ID: 20860867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conceptual disorganization weakens links in cognitive pathways: Disentangling neurocognition, social cognition, and metacognition in schizophrenia.
    Minor KS; Marggraf MP; Davis BJ; Luther L; Vohs JL; Buck KD; Lysaker PH
    Schizophr Res; 2015 Dec; 169(1-3):153-158. PubMed ID: 26441007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients.
    Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P
    Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social cognition and neurocognitive deficits in first-episode schizophrenia.
    Bliksted V; Fagerlund B; Weed E; Frith C; Videbech P
    Schizophr Res; 2014 Mar; 153(1-3):9-17. PubMed ID: 24480016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder.
    O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG
    BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review.
    Au-Yeung C; Penney D; Rae J; Carling H; Lassman L; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110833. PubMed ID: 37482283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up.
    Lewandowski KE; Cohen BM; Keshavan MS; Sperry SH; Ongür D
    Schizophr Res; 2013 Aug; 148(1-3):34-7. PubMed ID: 23791391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The centrality of cognitive symptoms and metacognition within the interacting network of symptoms, neurocognition, social cognition and metacognition in schizophrenia.
    Hasson-Ohayon I; Goldzweig G; Lavi-Rotenberg A; Luther L; Lysaker PH
    Schizophr Res; 2018 Dec; 202():260-266. PubMed ID: 30001972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery.
    Sperry SH; O'Connor LK; Öngür D; Cohen BM; Keshavan MS; Lewandowski KE
    J Int Neuropsychol Soc; 2015 Jul; 21(6):468-72. PubMed ID: 26154947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide.
    Potkin SG; Anand R; Alphs L; Fleming K
    Schizophr Res; 2003 Jan; 59(1):59-66. PubMed ID: 12413643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.
    Bowie CR; Depp C; McGrath JA; Wolyniec P; Mausbach BT; Thornquist MH; Luke J; Patterson TL; Harvey PD; Pulver AE
    Am J Psychiatry; 2010 Sep; 167(9):1116-24. PubMed ID: 20478878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder.
    Smith TE; Hull JW; Israel LM; Willson DF
    Schizophr Bull; 2000; 26(1):193-200. PubMed ID: 10755681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between neurocognition and functional recovery in first-episode schizophrenia: Results from the second year of the Oslo multi-follow-up study.
    Torgalsbøen AK; Mohn C; Czajkowski N; Rund BR
    Psychiatry Res; 2015 Jun; 227(2-3):185-91. PubMed ID: 25890693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensory processing, neurocognition, and social cognition in schizophrenia: towards a cohesive cognitive model.
    de Jong JJ; de Gelder B; Hodiamont PP
    Schizophr Res; 2013 May; 146(1-3):209-16. PubMed ID: 23522906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
    Lysaker PH; Kukla M; Dubreucq J; Gumley A; McLeod H; Vohs JL; Buck KD; Minor KS; Luther L; Leonhardt BL; Belanger EA; Popolo R; Dimaggio G
    Schizophr Res; 2015 Oct; 168(1-2):267-72. PubMed ID: 26164820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.